Connection

DAVID POPLACK to Leukemia

This is a "connection" page, showing publications DAVID POPLACK has written about Leukemia.
Connection Strength

0.577
  1. Central nervous system leukemia. Curr Opin Oncol. 1996 Jan; 8(1):13-9.
    View in: PubMed
    Score: 0.101
  2. Intrathecal 6-mercaptopurine: preclinical pharmacology, phase I/II trial, and pharmacokinetic study. Cancer Res. 1991 Nov 15; 51(22):6079-83.
    View in: PubMed
    Score: 0.076
  3. Current pharmacological treatment approaches to central nervous system leukaemia. Drugs. 1991 May; 41(5):702-16.
    View in: PubMed
    Score: 0.073
  4. Central nervous system pharmacology of antileukemic drugs. Am J Pediatr Hematol Oncol. 1989; 11(1):74-86.
    View in: PubMed
    Score: 0.062
  5. Differences in cerebrospinal fluid penetration of corticosteroids: possible relationship to the prevention of meningeal leukemia. J Clin Oncol. 1987 Feb; 5(2):202-7.
    View in: PubMed
    Score: 0.054
  6. Prophylaxis and treatment of leukemia in the central nervous system and other sanctuaries. Semin Oncol. 1985 Jun; 12(2):131-48.
    View in: PubMed
    Score: 0.048
  7. Current concepts. Biochemical markers in lymphoid malignancy. N Engl J Med. 1980 Oct 16; 303(16):918-22.
    View in: PubMed
    Score: 0.035
  8. Acute encephalopathy after initiation of cranial irradiation for meningeal leukaemia. Lancet. 1978 Jul 01; 2(8079):13-5.
    View in: PubMed
    Score: 0.030
  9. Modulation of the cytotoxic effect of cyclopentenylcytosine by its primary metabolite, cyclopentenyluridine. Cancer Res. 1992 Jun 15; 52(12):3503-5.
    View in: PubMed
    Score: 0.020
  10. Pharmacologic approaches to the treatment of meningeal malignancy. Oncology (Williston Park). 1991 May; 5(5):107-16; discussion 123, 127.
    View in: PubMed
    Score: 0.018
  11. Expression of interleukin-2 receptor beta subunit in hematopoietic malignancies. Blood. 1989 May 15; 73(7):1968-72.
    View in: PubMed
    Score: 0.016
  12. Cellular pharmacokinetics of mercaptopurine in human neoplastic cells and cell lines. Cancer Res. 1985 Sep; 45(9):4156-61.
    View in: PubMed
    Score: 0.012
  13. Cerebrospinal fluid pharmacokinetics of intraventricular and intravenous aziridinylbenzoquinone. Cancer Res. 1984 Apr; 44(4):1698-701.
    View in: PubMed
    Score: 0.011
  14. Duration of empiric antibiotic therapy in granulocytopenic patients with cancer. Am J Med. 1979 Aug; 67(2):194-200.
    View in: PubMed
    Score: 0.008
  15. Neurotoxicities of current leukemia therapy. Am J Pediatr Hematol Oncol. 1979; 1(2):127-40.
    View in: PubMed
    Score: 0.008
  16. Infectious complications of intraventricular reservoirs in cancer patients. Pediatr Infect Dis J. 1987 Feb; 6(2):182-9.
    View in: PubMed
    Score: 0.003
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.